Viking Therapeutics VKTX
NASDAQ VKTX
$36.75 -4.90 (-11.76%)
At close: Sep 24, 2026 · 4:00 PM EDT

Viking Therapeutics (VKTX) Preferred Shares (2024)

Viking Therapeutics' (VKTX) quarterly Preferred Shares came in at $10.0 million in Q1 2024.

Analysis

Viking Therapeutics (VKTX) Preferred Shares (2024) Analysis & Trends

Viking Therapeutics has disclosed Preferred Shares across 1 years of filings, most recently posting $10.0 million for Q1 2024.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn -
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn -
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn -
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn -
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn -
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn -
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn -
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn -
10 Viking Therapeutics 4.86 Bn 4.86 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 10.00 Mn
API Access

Viking Therapeutics Preferred Shares API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-shares&ticker=VKTX&period=max&api_key=YOUR_API_KEY